The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I personally found the interim report very encouraging, there were already trial delays to keep in mind as announced previously but now site openings and patient recruitment are picking up. More patients have entered the compassionate use program which is excellent news. The placing price is not really a surprise, the encouraging thing is costs have been kept to a controlled level compared to previous reports. The company is also picking up a nice level of R&D tax credits too. The share price is never going to take off until the 2018 interim data read out has been published and/or a licensing deal is announced.
I remember seeing in the last set of results Evgen are due to announce an interim update around 1Q 2018, I would expect the placing to coincide with this to take advantage of a (hopeful) spike in the share price. A definite LTH patience game in my opinion as the rewards could be spectacular.
Thanks for posting that. The company has some very interesting plans over the next 2 - 3 years.
An impressive trading update, glad to see the efficiency of the company's production line has improved markedly and the new products are due to launch soon. A bit of patience needed in my opinion but will be interesting to see how the share price progresses over the year.
I've had a look into this and found for larger patent cases it often takes around 4 - 6 weeks time, although this is a very rough average figure so please don't take this as gospel. It could take a lot longer.
Small free float from what I can see here which means plenty of MM games to try and panic PI's into selling.
Yes, plenty of future potential in here too. The chairman is making all the right noises about cautious expansion and glad to see they have orders from different continents around the world. The new technology sounds very promising plus the company already have developed a prototype which shows their commitment to upgrading their product offerings. Happy to hold here long term through what will be plenty of MM fun and games.
Indeed, its crunch time at the end of the month and hopefully the BoD's confidence is well-founded in that we'll get a favourable decision. Glad that the limbo state is finally drawing to a close anyway.
Once again it hits the 70's then its ass falls out. Unfortunately bored investors will continue to sell and mm's will drop the price back down. I would have liked to see more of a statement of intent from the BoD rather than preaching the cross-selling, which although an obvious advantage, seems a touch short-sighted when there seems to be a lack of a growth plan for the medium/long term.
I agree, this is a well run company and the latest results are testament to that, however I can't help but feeling a bit underwhelmed with the undervalued SP progress. Hopefully with the 2 acquisitions now settled the group can kick on and expand. Happy to be patient though, as this is one of those typical stocks that will start rising as soon as one sells!
Nice rise ahead of the results on 7/9. Very encouraging! Looking forward to hearing an update on the company's expansion plans.
A positive RNS this morning. Probably a reaction to knowing 1PM is the frontrunner for the 'Dullest Share of 2016' award.
Good to see BM commenting on the care taken over planning for large orders since this has been an issue in the past. A trading update in October shows their confidence going forwards. It will be interesting to hear BM's plans for the expansion of the company when the full year results are announced. With the new technology for 2017 and a solid growth plan in place (with help from the new auditors) this should be an exciting stock for the medium/long term.
Looks like the MM fun and games have started coaxing those panic sellers.
A very positive reaction to the change of auditors. Surprising but very welcome. Onwards and upwards.
Latest RNS regarding a holding increase cropping another 3% off the free float.
With the weak pound helping exports and possible government contract wins in the short term the next results in (presumably) December should look a lot better. The new technology licensed for products in 2017 also sounds very promising, especially with the Chairman putting his money where his mouth is earlier in the year. I think this will be a very interesting 18 months going forwards for the company. I wouldn't be surprised to see a couple of major I.I's. piling in very soon to get their share of the free float before it's hoovered up.
Hopefully this time we won't get a nosebleed when breaking into the 70's like usual.
Nice to see a bit of forward movement over the last couple of days maybe due to some good vibes regarding a trading update which should be due soon.
A good declaration of intent by the directors no doubt to calm investor fears on the recent drops. It will be interesting to see what level of growth the group can achieve over the next 6 - 12 months.